Submit

Provide your contact details to get access

Provided by

CPhI Annual Industry Report 2017

CPhI Annual Industry Report 2017 

Pharma Insights

The overall findings reveal that the trend towards the integration of pharmaceutical outsourcing continues, with single source providers in terms of development increasingly sought. However, acquisitions in the future will not be dominated by big deals and large mergers, but rather smaller commentary services and niche technologies to fill specific technology asset gaps. Furthermore, the industry is anticipating a large increase in the use of flow chemistry and fermentation technologies – but resistance to change may slow adoption significantly. The new US Government administration, the longer-term implications of drug pricing, and big pharma income repartitions are highlighted as the key unknowns and risks for CDMO sector.

Fix the following errors:
Hide